|
donor
|
CHEBI_17891 |
|
|
taurocholate
|
CHEBI_36257 |
|
|
EC 3.1.4.17 (3',5'-cyclic-nucleotide phosphodiesterase) inhibitor
|
CHEBI_50568 |
|
|
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor
|
CHEBI_50218 |
|
|
bile duct cancer
|
DOID_4606 |
|
|
biliary tract cancer
|
DOID_4607 |
|
|
bile duct disease
|
DOID_4138 |
|
|
hepatobiliary system cancer
|
DOID_0080355 |
|
|
EC 2.3.1.24 (sphingosine N-acyltransferase) inhibitor
|
CHEBI_62530 |
|
|
EC 2.3.1.* (acyltransferase transferring other than amino-acyl group) inhibitor
|
CHEBI_76878 |
|
|
anti-anaemic agent
|
CHEBI_75835 |
|
|
epidermolytic hyperkeratosis
|
DOID_4603 |
|
|
growth inhibition
|
BAO_0000094 |
|
|
inhibition
|
BAO_0000091 |
|
|
stimulation
|
BAO_0000093 |
|
|
ligand function mode of action
|
BAO_0000084 |
|
|
cytotoxicity
|
BAO_0000090 |
|
|
phenotypic mode of action
|
BAO_0080004 |
|
|
hemiplegia
|
DOID_10969 |
|
|
central nervous system disease
|
DOID_331 |
|
